Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc.

13.25
USD
+0.01
(+0.08%)
-3.06EPS
293.67MMarket Cap

Total Valuation

USD

As of March 31, 2026, Cross Country Healthcare, Inc. carries a market capitalization of 293.67M, placing it among publicly traded companies globally. Its enterprise value stands at 190.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap293.67M
Enterprise Value190.13M

Important Dates

Cross Country Healthcare, Inc.'s next confirmed earnings release is scheduled for August 5, 2026.

Earnings Date8/5/2026

Share Statistics

As of March 31, 2026, Cross Country Healthcare, Inc. has 31.24M shares outstanding.

Shares Outstanding31.24M

Valuation Ratios

These figures are as of March 31, 2026. The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.94.

PS Ratio0.30
PB Ratio0.94
P/TBV Ratio1.32
P/FCF Ratio7.64
P/OCF Ratio6.40

Enterprise Valuation

These figures are as of March 31, 2026. The EV/Sales ratio of 0.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 190.13M versus a market cap of 293.67M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.19

Financial Position

As of March 31, 2026, Cross Country Healthcare, Inc. maintains a current ratio of 3.29, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.65, indicating moderate leverage, while an interest coverage ratio of -32.10 demonstrates limited ability to service its debt obligations.

Current Ratio3.29
Quick Ratio3.20
Debt / Equity0.65
Debt / EBITDA-0.03
Interest Coverage-32.10

Financial Efficiency

USD

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. posted a negative return on equity (ROE) of -26.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -19.20, reflecting losses generated across the asset base. The company generates approximately 799,634.48 in revenue per employee across its workforce of 1,253.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-26.98
Return on Assets (ROA)-19.20
Revenue Per Employee799,634.48
Employee Count1,253.00

Taxes

USD

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. recorded 12.28M in income tax expense. The company reported a pretax loss of -86.34M and -98.63M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax12.28M

Stock Price Statistics

USD

As of the close on July 20, 2026, Cross Country Healthcare, Inc.'s stock has gained approximately 3.68% over the past 52 weeks. The 50-day moving average sits at 13.16, while the 200-day moving average is 10.76.

52-Week Price Change3.68%
50-Day Moving Average13.16
200-Day Moving Average10.76

Income Statement

USD

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. generated 1.00B in revenue and converted that into -98.63M in net income, yielding earnings per share of -3.06. EBITDA reached -71.90M, while operating income came in at -7.19M.

Revenue1.00B
Gross Profit202.50M
Operating Income-7.19M
Pretax Income-86.34M
Net Income-98.63M
EBITDA-71.90M
EBIT-87.59M
Earnings Per Share (EPS)-3.06

Balance Sheet

USD

As of March 31, 2026, Cross Country Healthcare, Inc. holds 105.58M in cash and equivalents against 2.04M in total debt, resulting in a net debt position of -105.58M. Total book value stands at 312.81M, with working capital of 207.73M providing operational flexibility.

Cash & Cash Equivalents105.58M
Total Debt2.04M
Net Debt-105.58M
Equity (Book Value)312.81M
Book Value Per Share10.01
Working Capital207.73M

Cash Flow

USD

Cross Country Healthcare, Inc. produced 47.34M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -7.73M in capital expenditures, free cash flow totaled 39.60M - equivalent to 1.23 per share.

Operating Cash Flow47.34M
Capital Expenditures-7.73M
Free Cash Flow39.60M
FCF Per Share1.23

Margins

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. posted a gross margin of 20.21, reflecting its pricing power and cost economics. The operating margin of -0.72 and net profit margin of -9.84 provide insight into operational efficiency.

Gross Margin20.21
Operating Margin-0.72
Pretax Margin-8.62
Profit Margin-9.84
EBITDA Margin-7.18

Dividends & Yields

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 13.08, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 5.02, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cross Country Healthcare, Inc. shareholders.

Shareholder Yield5.02
FCF Yield13.08

Scores

As of March 31, 2026, Cross Country Healthcare, Inc. has an Altman Z-Score of 5.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.13